[Skip to Content]
[Skip to Content Landing]
Citations 0
Letters
November 21, 2001

Guidelines for Diagnosis and Treatment of High Cholesterol—Reply

Author Affiliations
 

Stephen J.LurieMD, PhD, Senior EditorIndividualAuthorJody W.ZylkeMD, Contributing EditorIndividualAuthor

JAMA. 2001;286(19):2400-2402. doi:10.1001/jama.286.19.2398

In Reply: These letters raise interesting issues and question whether the NCEP-ATP III reached the right decisions on several aspects of the guidelines. Dr Feeman doubts that primary care physicians will use Framingham scoring in risk assessment. He proposes an alternate approach to risk assessment that in our view is even more complex than Framingham scoring. Moreover, in ATP III, Framingham scoring is added to a familiar risk assessment approach based on the algorithm used in ATP II. Framingham risk scoring is added to achieve a more tailored therapy for higher risk patients to ensure maximal benefit at greatest safety and lowest drug cost.

First Page Preview View Large
First page PDF preview
First page PDF preview
×